Checkout our iOS App for a better way to browser and research.
(1) There is created the Cannabinoid Product Board within the department.
(2) The department shall appoint, in consultation with a professional association based in the state that represents physicians, seven members to the Cannabinoid Product Board as follows:
(a) three individuals who are medical research professionals; and
(b) four physicians.
(3) The department shall ensure that at least one of the board members appointed under Subsection (2) is a member of the Controlled Substances Advisory Committee created in Section 58-38a-201.
(4)
(a) Four of the board members appointed under Subsection (2) shall serve an initial term of two years and three of the board members appointed under Subsection (2) shall serve an initial term of four years.
(b) Successor board members shall each serve a term of four years.
(5) The department may remove a board member without cause.
(6) The board shall nominate a board member to serve as chairperson of the board by a majority vote of the board members.
(7) The board shall meet as often as necessary to accomplish the duties assigned to the board under this chapter.
(8) Each board member, including the chair, has one vote.
(9)
(a) A majority of board members constitutes a quorum.
(b) A vote of a majority of the quorum at any board meeting is necessary to take action on behalf of the board.
(10) A board member may not receive compensation for the member's service on the board, but may, in accordance with rules adopted by the board in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, receive:
(a) per diem at the rate established under Section 63A-3-106; and
(b) travel expenses at the rate established under Section 63A-3-107.